High-Flow Nasal Cannula oxygen therapy in COVID-19: retrospective analysis of clinical outcomes – single center experience

BACKGROUND: High-Flow Nasal Cannula (HFNC) oxygen therapy emerged as the therapy of choice in COVID-19-related pneumonia and moderate to severe acute hypoxemic respiratory failure (AHRF). HFNC oxygen therapy in COVID-19 has been recommended based its use to treat AHRF of other etiologies, and studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Obradović, Dušanka, Milovančev, Aleksandra, Plećaš Đurić, Aleksandra, Sovilj-Gmizić, Stanislava, Đurović, Vladimir, Šović, Jovica, Đurđević, Miloš, Tubić, Stevan, Bulajić, Jelena, Mišić, Milena, Jojić, Jovana, Pušara, Miroslava, Lazić, Ivana, Đurković, Mladen, Bek Pupovac, Renata, Vulić, Aleksandra, Jozing, Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577378/
https://www.ncbi.nlm.nih.gov/pubmed/37849487
http://dx.doi.org/10.3389/fmed.2023.1244650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577378/
https://www.ncbi.nlm.nih.gov/pubmed/37849487
http://dx.doi.org/10.3389/fmed.2023.1244650

Ejemplares similares